CRISPR/Cas9 technology: from cells to mice to stem cell therapy by Te Riele, H, Harmsen, T, Van De Vrugt, H, Riepsaame, J

Effective CRISPR/Cas9-mediated correction of a Fanconi anemia defect by error-prone end joining or templated repair by Van De Vrugt, HJ, Harmsen, T, Riepsaame, J, Alexantya, G, Van Mil, SE, De Vries, Y, Bin Ali, R, Huijbers, IJ, Dorsman, JC, Wolthuis, RMF, Riele, H